Return to search

Vaccsys Raises $18 Million

Vaccsys Inc., a Seattle-based vaccine developer, has called down $9 million of an $18 million Series A round, according to a regulatory filing. Backers include Alta Partners, The Column Group and Versant Ventures. The company's technologies “regulate immune responses by targeting dendritic cell biology with combinations of proprietary vectors and adjuvants.”